Related Articles
Safety and Clinical outcomes of Pooled Donor, Nonengrafting Expanded Progenitor Cells in Single-Unit Cord Blood Transplantation
Adding an off-the=shelf, pooled, random-donor cord blood product to an HLA-matched single unit cord blood transplant for acute leukemia resulted in 96% disease free survival without any severe graft versus host disease.
April 2026